Volumetric MRI markers and predictors of disease activity in early multiple sclerosis: a longitudinal cohort study.
about
[Ultrahigh field MRI in context of neurological diseases].MRI correlates of disability progression in patients with CIS over 48 months.Corpus callosum atrophy correlates with gray matter atrophy in patients with multiple sclerosis.Corpus callosum atrophy rate in mild cognitive impairment and prodromal Alzheimer's disease.Quantitative evaluation of cerebral white matter in patients with multiple sclerosis using multicomponent T2 mapping.Clinical relevance of brain atrophy assessment in multiple sclerosis. Implications for its use in a clinical routine.Protective associations of HDL with blood-brain barrier injury in multiple sclerosis patients.MRI in the assessment and monitoring of multiple sclerosis: an update on best practice.The prognostic utility of MRI in clinically isolated syndrome: a literature review.A Novel Semiautomated Pipeline to Measure Brain Atrophy and Lesion Burden in Multiple Sclerosis: A Long-Term Comparative Study.Midsagittal corpus callosum area and conversion to multiple sclerosis after clinically isolated syndrome: A multicentre Australian cohort study.The yearly rate of Relative Thalamic Atrophy (yrRTA): a simple 2D/3D method for estimating deep gray matter atrophy in Multiple SclerosisIdentification of multiple sclerosis patients at highest risk of cognitive impairment using an integrated brain magnetic resonance imaging assessment approach.Predictors of long-term disability accrual in relapse-onset multiple sclerosis.Contribution of different relapse phenotypes to disability in multiple sclerosis.Defining and scoring response to IFN-β in multiple sclerosis.Cognitive clinico-radiological paradox in early stages of multiple sclerosis.Pathological cut-offs of global and regional brain volume loss in multiple sclerosis.Multiple sclerosis susceptibility loci do not alter clinical and MRI outcomes in clinically isolated syndrome.Longitudinal Mixed-Effect Model Analysis of the Association between Global and Tissue-Specific Brain Atrophy and Lesion Accumulation in Patients with Clinically Isolated Syndrome.Early magnetic resonance imaging predictors of clinical progression after 48 months in clinically isolated syndrome patients treated with intramuscular interferon β-1a.Thalamic Iron Differentiates Primary-Progressive and Relapsing-Remitting Multiple Sclerosis.MRI-Defined Corpus Callosal Atrophy in Multiple Sclerosis: A Comparison of Volumetric Measurements, Corpus Callosum Area and Index.Longitudinal MRI and neuropsychological assessment of patients with clinically isolated syndrome.Is no evidence of disease activity an achievable goal in MS patients on intramuscular interferon beta-1a treatment over long-term follow-up?A serial 10-year follow-up study of brain atrophy and disability progression in RRMS patients.Sex as a determinant of relapse incidence and progressive course of multiple sclerosis.Combining clinical and magnetic resonance imaging markers enhances prediction of 12-year disability in multiple sclerosis.Increased albumin quotient (QAlb) in patients after first clinical event suggestive of multiple sclerosis is associated with development of brain atrophy and greater disability 48 months later.Risk of relapse phenotype recurrence in multiple sclerosis.Searching for neurodegeneration in multiple sclerosis at clinical onset: Diagnostic value of biomarkers.Clinical impact of early brain atrophy in clinically isolated syndromes
P2860
Q30759627-53B4D1A0-476D-4E94-8BDA-B77CFF78F721Q34431806-6A396430-D6DD-4606-BE6F-5E960A2F0EB9Q34696441-D541EC2F-1D85-4FF5-942D-5924B0D8B904Q35673511-A7635891-8C9A-4392-8E3D-91C9B0CA65D4Q35990016-219123E5-B44F-471E-9E0F-BC43F68A18F2Q35997017-11AF057C-1037-4009-8EC4-992F29848659Q36093231-CB1642BC-5D63-4E81-B242-F852B6D11E61Q36400004-E2EC8ABE-56E0-4479-AA5D-6BA1D2562968Q38211996-902585D4-325B-4F90-94BF-411321C9C1F2Q38808604-835F89B8-FA44-4A4E-8074-E72C187BF543Q39044303-EB465CE6-7136-4DFE-89DE-59636BF73B8FQ39131745-1C5C563A-2973-4C31-8946-69F2AAF707BAQ39165460-D1C8DE31-50D1-4AC1-9063-96F294A7F11DQ39795220-4277DA85-B118-469C-913D-B2AAAC08F06AQ40724148-FE80D98F-7399-4EA8-8892-10AFB938938FQ46023940-EECBE14A-5878-42CC-8DFF-04C3509F49C0Q47835663-C68BDF49-8CC2-404E-A4FA-DBA4603C150FQ47967210-78EF868F-7DCE-44B2-AFB2-993896D0FE04Q48088336-09DFBDDB-FB39-4604-8693-0AEADE21499AQ48108313-A96E2AD4-6BC2-4CE6-81CB-465CB8A13A35Q48215414-2E706F4E-9975-48A5-9EF4-DCF1F4563B69Q48222881-D058A6A5-46DA-4BCE-A70F-988C904499D6Q48274196-09089FA6-3BB9-47C1-925B-E33C7580A6A7Q48704199-EBBF2716-7662-43DE-9C65-053611159F75Q48711608-3E2FC7C2-BC98-4194-9B81-9FCD6E114ACCQ48901292-8942CF8F-FA3B-4247-A4FC-F640300FF970Q48922719-0DD926B5-E451-4652-9B8F-6D920221BB4CQ52141693-355A9732-E8D4-4B55-AECB-F30F3739B508Q52149416-80F61A05-AE53-4C08-9363-2FD54EBCB84FQ53090722-48E80739-CF44-43B3-8639-AE0257B885E9Q55402326-EF50008E-C980-4ECD-9BCE-95D6D80DE331Q57601852-4ACA6109-B04A-487F-A4E6-04D577D828B3
P2860
Volumetric MRI markers and predictors of disease activity in early multiple sclerosis: a longitudinal cohort study.
description
2012 nî lūn-bûn
@nan
2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Volumetric MRI markers and pre ...... : a longitudinal cohort study.
@ast
Volumetric MRI markers and pre ...... : a longitudinal cohort study.
@en
Volumetric MRI markers and pre ...... : a longitudinal cohort study.
@nl
type
label
Volumetric MRI markers and pre ...... : a longitudinal cohort study.
@ast
Volumetric MRI markers and pre ...... : a longitudinal cohort study.
@en
Volumetric MRI markers and pre ...... : a longitudinal cohort study.
@nl
prefLabel
Volumetric MRI markers and pre ...... : a longitudinal cohort study.
@ast
Volumetric MRI markers and pre ...... : a longitudinal cohort study.
@en
Volumetric MRI markers and pre ...... : a longitudinal cohort study.
@nl
P2093
P2860
P50
P1433
P1476
Volumetric MRI markers and pre ...... : a longitudinal cohort study.
@en
P2093
Jan Krasensky
Manuela Vaneckova
Zdenek Seidl
P2860
P304
P356
10.1371/JOURNAL.PONE.0050101
P407
P577
2012-11-15T00:00:00Z